Qingyang Sun
Suqian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Transcription Factor HOXC11 Drives Colorectal Cancer Progression and Metastasis via CAMK2A-Dependent CXCL5 Upregulation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 28, 2026
ENO2 drives tumor cell-induced M2 macrophage polarization to promote colorectal cancer liver metastasis.
Journal: Signal transduction and targeted therapy
Published: February 12, 2025
Dual Role of CRABP2 in Colorectal Cancer: Oncogenesis via Nuclear RB1 and Cytoplasmic AFG3L2/SLC25A39 Axis, While Limiting Liver Metastasis through Cytoplasmic AFG3L2/PINK1/Parkin-Mediated Mitophagy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 09, 2025
PJA2 Suppresses Colorectal Cancer Progression by Controlling HDAC2 Degradation and Stability.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 24, 2024
KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2.
Journal: Acta pharmaceutica Sinica. B
Published: January 13, 2024
Single-Cell and Spatial Transcriptome Profiling Identifies the Transcription Factor BHLHE40 as a Driver of EMT in Metastatic Colorectal Cancer.
Journal: Cancer research
Published: October 19, 2023
Promotion of colorectal cancer progression by immune-related lnc-SOX9-4 via suppression of YBX1 poly-ubiquitination and degradation.
Journal: Cellular signalling
Published: June 03, 2023
Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 27, 2022
UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3.
Journal: Oncogene
Published: July 19, 2022
Soluble programmed death ligand-1-induced immunosuppressive effects on chimeric antigen receptor-natural killer cells targeting Glypican-3 in hepatocellular carcinoma.
Journal: Immunology
Published: July 03, 2022
A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.
Journal: Frontiers in oncology
Published: May 03, 2022
Last Updated: 09/26/2026